XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 111 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,641,920 | $10,493,971 | 39.87% |
| Stonepine Capital Management, LLC | 5,915,372 | $11,002,592 | 3.66% |
| MPM BioImpact LLC | 3,987,967 | $7,417,619 | 1.98% |
| SINECERA CAPITAL, LLC | 253,101 | $470,768 | 0.63% |
| Opaleye Management Inc. | 390,000 | $725,400 | 0.24% |
| Alpine Global Management, LLC | 300,000 | $558,000 | 0.14% |
| DELTEC ASSET MANAGEMENT LLC | 315,246 | $586,358 | 0.13% |
| Redmile Group, LLC | 1,046,587 | $1,946,652 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 381,231 | $709 | 0.06% |
| Soleus Capital Management, L.P. | 304,083 | $565,594 | 0.05% |
| TANG CAPITAL MANAGEMENT LLC | 150,000 | $279,000 | 0.04% |
| IHT Wealth Management, LLC | 284,392 | $528,972 | 0.03% |
| GPS Wealth Strategies Group, LLC | 64,025 | $119,087 | 0.02% |
| Fairfax Financial Holdings | 151,395 | $281,595 | 0.02% |
| Diversified Trust Co | 175,407 | $326,257 | 0.01% |
| Annandale Capital, LLC | 25,000 | $47 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 641,498 | $1,193,186 | 0.01% |
| Veery Capital, LLC | 12,544 | $23,332 | 0.01% |
| Goldstein Advisors, LLC | 25,425 | $47,291 | 0.01% |
| WHITENER CAPITAL MANAGEMENT, INC. | 12,000 | $22,320 | 0.01% |
This page lists XERIS BIOPHARMA HOLDINGS INC's shareholders in Q3 2023. To view XERIS BIOPHARMA HOLDINGS INC's shareholder history, click here.